Medication-Assisted Treatment (MAT)

Offers resources and information about implementing trauma-informed and recovery-oriented approaches to treat people with substance use disorders, including developing coordinated systems of care, with examples from a completed pilot project in Indiana

Provides primary care providers with information about the changing landscape of alcohol use disorder and other alcohol-related problems and how best to address problematic alcohol use

The Health Resources & Services Administration funded Substance Use Warmline (855-300-3595, nccc.ucsf.edu) is pleased to offer confidential, free teleconsultation to clinicians on substance use evaluation and management

Report to Congress describing different options for medication-assisted treatment (MAT) for substance use disorders, Federal and State policies outlining Medicaid coverage for MAT across the United States, and summarizing utilization of MAT among Medicaid beneficiaries

One of SAMHSA's series of advisories based on TIP 49, which provides an overview of medications for treatment of alcohol use disorder

Provides general information about telehealth, changes to policies during COVID-19, planning telehealth workflows, preparing patients for telehealth visits, billing and reimbursement, legal considerations, privacy and security, telehealth vendors and platforms, and best practices

Provides high-level overview of medication-assisted treatment for alcohol use disorder, including descriptions and potential side effects of acamprosate, disulfiram, naltrexone, and topiramate

Summarizes medication-assisted treatment (MAT) as an effective tool in treating alcohol use disorder (AUD) and reviews specific medications approved for MAT for AUD

Report that offers a literature review and summary of 21 key informant interviews with harm reduction staff from across the United States

Provides guidance on medication-assisted treatment for unhealthy alcohol use, specifically on benzodiazepines, during the COVID-19 pandemic